Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $46.96 +7.66%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Canada's Competition Bureau moves to block B&G Foods' Green Giant sale
- Ck Hutch Seeks Over $1.5b For Destruction Of Panama Investments - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
